Home › Compare › GMSQF vs ABBV
GMSQF yields 1481.48% · ABBV yields 3.06%● Live data
📍 GMSQF pulled ahead of the other in Year 1
Combined, GMSQF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GMSQF + ABBV for your $10,000?
GameSquare Esports Inc., through its subsidiaries, operates as a gaming and esports company in Canada. The company operates in two segments, Teams, and Agency Services. The Teams segment provides sponsorships, prizes, and players to teams. The Agency Services segment represents esports players and influencers, including Twitch streamers, YouTubers, and gaming personalities, as well as other on-screen talent, such as commentators, analysts, event hosts, and production crew. This segment also provides consulting services to individuals and businesses operating in various roles in the esports industry, including ventures, sponsors, and investors; tournament organizers; game publishers and developers; and producers and broadcasters, as well as advises players, influencers, and other on-screen talent in the esports industry on matters relating to the production of events and campaigns. In addition, this segment offers digital media, as well as gaming and lifestyle marketing agency services. GameSquare Esports Inc. is based in Toronto, Canada.
Full GMSQF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.